Name (Synonyms) | Correlation | |
---|---|---|
drug114 | AVIGAN 200 mg FT Wiki | 1.00 |
drug2748 | Streptokinase Wiki | 1.00 |
drug3009 | Unfractionated heparin Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.10 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.09 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.08 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A single dose of Reference product containing 200 mg favipiravir and a single dose of Test product containing 200 mg favipiravir or vice versa; administered with 240 mL of water at room temperature, in each period under fasting conditions with current pandemic precautions.
Description: AUC0-tlast of favipiravir obtained by plasma concentration
Measure: AUC0-tlast of favipiravir Time: 0 to 24 hours post-doseDescription: Cmax of favipiravir obtained by plasma concentration
Measure: Cmax of favipiravir Time: 0 to 24 hours post-doseDescription: AUC0-inf of favipiravir obtained by plasma concentration
Measure: AUC0-inf of favipiravir Time: 0 to 24 hours post-doseDescription: tmax of favipiravir obtained by plasma concentration
Measure: tmax of favipiravir Time: 0 to 24 hours post-dose